DCGI suspends Serum Institute`s phase 2, 3 clinical trials of AstraZeneca`s COVID-19 vaccine

The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.

https://ift.tt/eA8V8J from https://ift.tt/33nbJzu

ليست هناك تعليقات:

إرسال تعليق

Punjab govt announces Rs 1 crore cash award to India men`s hockey team players from the state

Indian men's hockey team on Thursday morning created history at the Tokyo Olympics by winning a bronze, their first medal in 41 years fr...